To confirm the above proposal, the effects of different inhibitors on cell viability and apoptosis in CRC cell lines were evaluated, including F4 for c-Myc, Rux for STAT3, Bay for NF-κB, and 4EGI for eIF4E–eIF4G interaction. This evidence concerns the gene MYC and colorectal carcinoma.